Aprea Therapeutics Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

1.66

-0.09 (-5.14%)

At close: Apr 29, 2025, 3:59 PM

1.66

0.00%

After-hours: Apr 29, 2025, 04:01 PM EDT

Aprea Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	22.85M	21.61M	28.79M	53.08M	89.02M	130.09M	65.68M	24.4M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	40.72K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	321.83K	n/a	n/a	n/a	n/a	n/a	111.00	121.00
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	726.25K	914.27K	1.37M	3.51M	3.4M	2.96M	n/a	n/a
Total Current Assets	23.58M	22.52M	30.15M	56.58M	92.42M	133.04M	66M	24.73M
Property-Plant & Equipment	81.52K	88.36K	2.32K	239.05K	388.51K	563.14K	24.45K	30.34K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	403.35K	129.08K	2.32K	239.05K	388.51K	563.14K	24.56K	30.46K
Total Assets	23.98M	22.65M	30.16M	56.82M	92.81M	133.61M	66.02M	24.76M
Account Payables	1.35M	1.67M	842.75K	1.77M	4.5M	2.18M	1.74M	1.66M
Deferred Revenue	n/a	528.97K	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	190.47K	256.31K	242.33K	n/a	n/a
Other Current Liabilities	465.01K	1.17M	960.36K	3.74M	8.8M	5.44M	2.5M	1.92M
Total Current Liabilities	3.36M	4.39M	3.2M	7.32M	15.33M	9.06M	4.87M	4.3M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.31M	1.31M	1.31M	n/a	n/a	n/a	112.59M	56.23M
Total Long-Term Liabilities	1.31M	1.31M	1.31M	n/a	78.85K	302.62K	112.59M	56.23M
Total Liabilities	4.67M	5.7M	4.51M	7.32M	15.41M	9.36M	117.46M	60.53M
Total Debt	n/a	n/a	n/a	190.47K	335.16K	544.95K	n/a	n/a
Common Stock	5.48K	3.74K	2.65K	21.86K	21.19K	21.02K	127.09K	126.84K
Retained Earnings	-321.04M	-308.08M	-293.8M	-181.13M	-144.01M	-90.53M	-62.47M	-46.94M
Comprehensive Income	-10.63M	-10.61M	-10.62M	-10.36M	-10.04M	-11.53M	-8.76M	-8.29M
Shareholders Equity	19.31M	18.26M	25.64M	49.51M	77.4M	124.24M	-51.44M	-35.77M
Total Investments	n/a	40.72K	n/a	n/a	n/a	n/a	n/a	n/a